DavidJCutter's profile picture. Clinical Oncologist at Oxford Cancer Centre and Associate Professor at the University of Oxford.
@ChelseaFC fan. Opinions are mine.

David Cutter

@DavidJCutter

Clinical Oncologist at Oxford Cancer Centre and Associate Professor at the University of Oxford. @ChelseaFC fan. Opinions are mine.

David Cutter reposted

If you’re at #ICML2025 come by my poster 1230-1300. We examine survival by anthracycline use in older cHL patients. TLDR: use anthracycline if at all possible! @DavidJCutter @graham74GC

ABarrettHaem's tweet image. If you’re at #ICML2025 come by my poster 1230-1300. We examine survival by anthracycline use in older cHL patients. TLDR: use anthracycline if at all possible! @DavidJCutter @graham74GC

David Cutter reposted

📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups @Annals_Oncology doi.org/10.1016/j.anno…! Great GHSG team effort @B_von_Tresckow @UniklinikEssen @UKKoeln 🎉

BroeckelmannPJ's tweet image. 📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups @Annals_Oncology doi.org/10.1016/j.anno…! Great GHSG team effort @B_von_Tresckow @UniklinikEssen @UKKoeln 🎉
BroeckelmannPJ's tweet image. 📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups @Annals_Oncology doi.org/10.1016/j.anno…! Great GHSG team effort @B_von_Tresckow @UniklinikEssen @UKKoeln 🎉
BroeckelmannPJ's tweet image. 📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups @Annals_Oncology doi.org/10.1016/j.anno…! Great GHSG team effort @B_von_Tresckow @UniklinikEssen @UKKoeln 🎉
BroeckelmannPJ's tweet image. 📄📣 Analyzing >10,000 patients treated in randomized GHSG trials, we show strong correlation of PFS and OS after Hodgkin lymphoma first-line treatment across risk groups @Annals_Oncology doi.org/10.1016/j.anno…! Great GHSG team effort @B_von_Tresckow @UniklinikEssen @UKKoeln 🎉

David Cutter reposted

📢Our latest newsletter provides updates on: State of the Nation reporting, our Quarterly Clinical Performance Indicator report, the recent @NATCAN_news webinar & details of the latest report from @bloodcancer_uk 📰 bit.ly/4i2c1Br @HQIP @LymphomaAction @Ed_Pinches #NHL

NNHLA_NATCAN's tweet image. 📢Our latest newsletter provides updates on: State of the Nation reporting, our Quarterly Clinical Performance Indicator report, the recent @NATCAN_news webinar & details of the latest report from @bloodcancer_uk 📰 bit.ly/4i2c1Br @HQIP  @LymphomaAction @Ed_Pinches #NHL

David Cutter reposted

Out this week, this new publication explores how the distribution of trial site locations, may lead to disparities in patient representation in clinical trials. bit.ly/416VENC @DavidJCutter @LymphomaAction @bloodcancer_uk @NATCAN_news @WileyGlobal @NHSEngland @HQIP

NNHLA_NATCAN's tweet image. Out this week, this new publication explores how the distribution of trial site locations, may lead to disparities in patient representation in clinical trials. bit.ly/416VENC @DavidJCutter @LymphomaAction @bloodcancer_uk @NATCAN_news  @WileyGlobal @NHSEngland @HQIP

David Cutter reposted

Having learned every @BritSocHaem guideline off by heart for my FRCPath, it was very exciting to have been afforded the opportunity to lead an amazing group of co-authors for our GPP regarding bleomycin use in Hodgkin Lymphoma- published today! onlinelibrary.wiley.com/doi/10.1111/bj…


David Cutter reposted

Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity. onlinelibrary.wiley.com/doi/full/10.11…

radioncoluis's tweet image. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity.
onlinelibrary.wiley.com/doi/full/10.11…

David Cutter reposted

The #UKLRG meeting offers opportunities to ask questions, debate issues of interest in clinical practice, hear updates on UK #clinicaltrials and review advances in #lymphoma #radiotherapy techniques. Join us in London 27 Jan: lymphoma-action.org.uk/UKLRG @PattyDiezH @GeorgeMikhaeel

lymphoma_soph's tweet image. The #UKLRG meeting offers opportunities to ask questions, debate issues of interest in clinical practice, hear updates on UK #clinicaltrials and review advances in #lymphoma #radiotherapy techniques. Join us in London 27 Jan: lymphoma-action.org.uk/UKLRG @PattyDiezH @GeorgeMikhaeel

David Cutter reposted

Steve Ansell highlighting late effects of our treatment. No ‘safe dose’ of dox with respect to cardiac toxicity. Good data for dexrazoxane cardio protection with no evidence of ‘tumour protection’. #ISHL13 #lymsm

graham74GC's tweet image. Steve Ansell highlighting late effects of our treatment. No ‘safe dose’ of dox with respect to cardiac toxicity. Good data for dexrazoxane cardio protection with no evidence of ‘tumour protection’. #ISHL13 #lymsm
graham74GC's tweet image. Steve Ansell highlighting late effects of our treatment. No ‘safe dose’ of dox with respect to cardiac toxicity. Good data for dexrazoxane cardio protection with no evidence of ‘tumour protection’. #ISHL13 #lymsm
graham74GC's tweet image. Steve Ansell highlighting late effects of our treatment. No ‘safe dose’ of dox with respect to cardiac toxicity. Good data for dexrazoxane cardio protection with no evidence of ‘tumour protection’. #ISHL13 #lymsm

David Cutter reposted

Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !

glimelius's tweet image. Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !
glimelius's tweet image. Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !
glimelius's tweet image. Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !
glimelius's tweet image. Abscopal effect does exist in #Hodgkin lymphoma when RT 20Gy is given to PD-1 treated patiens. New distant responses seen outside RT fields. Pembro-RT an option in R/R HL with limited disease #ISHL13 #lymsm dr Christian Bauses. Also safe with RT with low doses! AERN trial !

David Cutter reposted

Thanks to Rajana Advani for including our data in the Best of #ISHL13 session. What a phenomenal three days- so much exciting science and practice-changing trial data, and so many new friends made with exciting future collaboration potential.

ABarrettHaem's tweet image. Thanks to Rajana Advani for including our data in the Best of #ISHL13 session. What a phenomenal three days- so much exciting science and practice-changing trial data, and so many new friends made with exciting future collaboration potential.

David Cutter reposted

Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm

graham74GC's tweet image. Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm
graham74GC's tweet image. Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm
graham74GC's tweet image. Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm
graham74GC's tweet image. Great presentation by @ABarrettHaem on the NHSE dataset of older pts with Hodgkin lymphoma. ABVD assoc with best outcomes but of course used in fitter pts. Profound impact of age, PS, comorbidities in this age group. #ISHL13 #lymsm

David Cutter reposted

Fascinating - the hospital at which a patient with Hodgkin lymphoma is treated in England has more effect on the variation in radiotherapy usage than sex of the patient. Suggests standardisation of approach is not yet achieved! #ISHL13 #lymsm. @DavidJCutter @DavidAdrwJones

graham74GC's tweet image. Fascinating - the hospital at which a patient with Hodgkin lymphoma is treated in England has more effect on the variation in radiotherapy usage than sex of the patient. Suggests standardisation of approach is not yet achieved! #ISHL13 #lymsm. @DavidJCutter @DavidAdrwJones

David Cutter reposted

Excited to be here at #ISHL13 , come along Sunday at 3pm for my talk about our registry analysis @DavidJCutter and swing by our posters regarding translational analysis of the ANIMATE study and our data collection project HoOP @graham74GC #hodgkinlymphoma

ABarrettHaem's tweet image. Excited to be here at #ISHL13 , come along Sunday at 3pm for my talk about our registry analysis @DavidJCutter and swing by our posters regarding translational analysis of the ANIMATE study and our data collection project HoOP @graham74GC #hodgkinlymphoma

David Cutter reposted

We promised you something exciting was coming... Our first quarterly report which includes clinical performance indicators & is presented on a new,highly interactive dashboard! 💥 bit.ly/3Ni3PyL @HQIP @LymphomaAction @bloodcancer_uk @DavidJCutter @KateWalkerLon #NHL


David Cutter reposted

Watch this space! 👀Our latest NNHLA quarterly report is out tomorrow. We won't spoil the surprise, but we've been working on some changes and this time something is different!..... 🤫🏥📊🔎 @HQIP @JillStoddart @bloodcancer_uk @LymphomaAction @BritSocHaem @DavidJCutter


David Cutter reposted

📢💥It's here! We are delighted to share our first State of the Nation report; along with a number of supplementary materials. Our thanks to everyone involved in its development. bit.ly/3XmI5q7 @HQIP @LymphomaAction @bloodcancer_uk @DavidJCutter @KateWalkerLon

NNHLA_NATCAN's tweet image. 📢💥It's here! We are delighted to share our first State of the Nation report; along with a number of supplementary materials. Our thanks to everyone involved in its development.  bit.ly/3XmI5q7
@HQIP @LymphomaAction @bloodcancer_uk @DavidJCutter @KateWalkerLon

David Cutter reposted

Exciting news! ⭐️The first NNHLA State of the Nation report is out tomorrow! Check this space or the @NATCAN_news webpages for details bit.ly/3TkRE7J #BCAM @LymphomaAction @bloodcancer_uk @LLSusa @AnthonyNolan @HQIP @NHSEngland @DavidJCutter @macmillancancer @MJAhearne


David Cutter reposted

The NNHLA Quality Improvement Plan has landed! The plan sets out: ⭐️5 QI goals ⭐️11 performance indicators Read the full report here bit.ly/3AKNvmX @LymphomaAction @LLSusa @bloodcancer_uk @BritSocHaem @AnthonyNolan @HQIP @JillStoddart @DavidJCutter @KateWalkerLon

natcan.org.uk

NNHLA Quality Improvement Plan 2024 - National Cancer Audit Collaborating Centre

NNHLA Quality Improvement Plan 2024 The Quality Improvement Plan describes the approach taken across the NATCAN cancer audits to develop improvement goals and performance indicators, ensuring these...

📢 The new Quality Improvement (QI) Plans are live! Read them here bit.ly/4gag9OL💡 The audits have developed key QI goals and performance indicators to monitor progress, aiming for these to be measurable, actionable, and improvable. @RCSnews @HQIP @NHSEngland @LSHTM

NATCAN_news's tweet image. 📢 The new Quality Improvement (QI) Plans are live!

Read them here bit.ly/4gag9OL💡

The audits have developed key QI goals and performance indicators to monitor progress, aiming for these to be measurable, actionable, and improvable.

@RCSnews @HQIP @NHSEngland @LSHTM


Loading...

Something went wrong.


Something went wrong.